We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+6.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$32.4B
AUM Growth
+$1.3B
Cap. Flow
-$612M
Cap. Flow %
-1.89%
Top 10 Hldgs %
20.55%
Holding
2,157
New
184
Increased
710
Reduced
919
Closed
201

Top Buys

Rank Stock Value
1
GIS icon
General Mills
GIS
+$167M
2
CVX icon
Chevron
CVX
+$114M
3
T icon
AT&T
T
+$89.6M
4
KMI icon
Kinder Morgan
KMI
+$71.1M
5
LUMN icon
Lumen
LUMN
+$45.2M

Sector Composition

Rank Sector Weight
1 Healthcare 14.55%
2 Consumer Staples 14.38%
3 Financials 9.62%
4 Utilities 8.65%
5 Technology 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMPH icon
1001
Amphastar Pharmaceuticals
AMPH
$1.02B
$1.75M 0.01%
150,760
-423,040
-74% -$4.61M
TMH
1002
DELISTED
Team Health Holdings Inc
TMH
$1.75M 0.01%
30,409
-9,071
-23% -$523K
CVG
1003
DELISTED
Convergys
CVG
$1.75M 0.01%
85,733
+15,596
+22% +$310K
BIO icon
1004
Bio-Rad Laboratories Class A
BIO
$10.1B
$1.74M 0.01%
14,421
-7,057
-33% -$812K
SSNC icon
1005
SS&C Technologies
SSNC
$18.9B
$1.74M 0.01%
59,456
+31,446
+112% +$779K
ALLE icon
1006
Allegion
ALLE
$13B
$1.73M 0.01%
31,251
-87,673
-74% -$4.55M
CRL icon
1007
Charles River Laboratories
CRL
$13.1B
$1.73M 0.01%
27,260
-11,053
-29% -$693K
EPAM icon
1008
EPAM Systems
EPAM
$6.04B
$1.73M 0.01%
36,292
+22,340
+160% +$1.05M
PIPR icon
1009
Piper Sandler
PIPR
$5.04B
$1.73M 0.01%
119,144
-724
-0.6% -$9.94K
STOR
1010
DELISTED
STORE Capital Corporation
STOR
$1.73M 0.01%
+80,000
New +$1.65M
BALL icon
1011
Ball Corp
BALL
$16.2B
$1.73M 0.01%
50,644
+648
+1% +$21.3K
LOGM
1012
DELISTED
LogMein, Inc.
LOGM
$1.72M 0.01%
34,899
+25,324
+264% +$1.21M
PNR icon
1013
Pentair
PNR
$9.01B
$1.72M 0.01%
38,590
+22,561
+141% +$990K
MHFI
1014
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$1.72M 0.01%
19,314
-38,593
-67% -$3.39M
BEN icon
1015
Franklin Templeton
BEN
$16.6B
$1.72M 0.01%
30,996
+1,270
+4% +$70.2K
SAIC icon
1016
Saic
SAIC
$5.56B
$1.71M 0.01%
34,615
+7,318
+27% +$357K
HUN icon
1017
Huntsman Corp
HUN
$1.61B
$1.71M 0.01%
75,075
-693,139
-90% -$16.8M
ITRI icon
1018
Itron
ITRI
$4.03B
$1.71M 0.01%
40,342
+6,699
+20% +$267K
VCYT icon
1019
Veracyte
VCYT
$3.1B
$1.7M 0.01%
176,400
-204,100
-54% -$1.59M
GPOR
1020
DELISTED
Gulfport Energy Corp.
GPOR
$1.7M 0.01%
40,721
-5,077
-11% -$238K
CMP icon
1021
Compass Minerals
CMP
$1B
$1.69M 0.01%
19,427
-907
-4% -$77.8K
SXT icon
1022
Sensient Technologies
SXT
$5.46B
$1.68M 0.01%
27,868
-1,148
-4% -$65.7K
OUTR
1023
DELISTED
OUTERWALL INC
OUTR
$1.67M 0.01%
22,211
-119
-0.5% -$7.62K
RYN icon
1024
Rayonier
RYN
$5.96B
$1.66M 0.01%
65,626
-6,032
-8% -$162K
ANN
1025
DELISTED
ANN INC
ANN
$1.66M 0.01%
45,455
+1,580
+4% +$59.5K

Similar funds

Federated Hermes's Q4 2014 Portfolio in Review

As of Q4 2014, Federated Hermes held 2,157 positions worth $32.4B, up 4.2% from $31.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Federated Hermes's Q4 2014 filing shows 184 new, 710 increased, 919 reduced and 201 closed positions. Its largest new stake was Dynegy Inc.: 358,499 shares worth $36.6M. The largest sale was Eli Lilly, an estimated $206M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Consumer Staples and Financials.

  • Federated Hermes's largest Q4 2014 buy was Dynegy Inc.: 358,499 shares worth $36.6M.
  • Federated Hermes added most to General Mills in Q4 2014, an estimated $167M increase.
  • Federated Hermes's biggest Q4 2014 reduction was Eli Lilly, cutting an estimated $206M.
  • Federated Hermes fully exited Core Laboratories in Q4 2014, selling an estimated $46.8M.
  • Federated Hermes's ten largest holdings make up 21% of its $32.4B portfolio in Q4 2014.
  • Federated Hermes opened 184 new positions and closed 201 in Q4 2014.
  • Federated Hermes's portfolio value rose 4.2% quarter-over-quarter to $32.4B.

Based on Federated Hermes's 13F filing for Q4 2014, filed 10 Feb 2015.